GlassScriptPhysician profile
Shirene Tabarestani
NPI 1902578016
$2,995.82
in general payments reported to CMS, 2019-2025
13 companies · $1,319 in 2025
The $1,319 reported for 2025 was more than what 87% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $645 · 2023: $227 · 2024: $805 · 2025: $1,319.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,351.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,350.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $1,326.09 | 2022-2025 | Atricure Cryoice Cryosphere Cryoablation System, Atricure Cryoice Cryoablation System (Cryo2), Atriclip Laa Exclusion System |
| Edwards Lifesciences Corporation | $692.98 | 2022-2025 | Konect Resilia |
| Baxter Healthcare | $165.70 | 2025 | Perclot |
| Cvrx, INC. | $158.61 | 2023 | Barostim Neo System |
| Solventum Corporation | $142.40 | 2024 | Prevena, V.A.C.Ulta, V.A.C. Veraflo Cleanse Choice |
| Si-Bone, INC. | $121.25 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $117.18 | 2022 | |
| Abiomed | $98.18 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $90.15 | 2025 | Lifevest |
| Abbott Laboratories | $25.99 | 2025 | Navitor |
| Medtronic, INC. | $22.11 | 2024 | Illumisite |
| Bard Peripheral Vascular, INC. | $19.66 | 2023 | |
| Kci USA, INC. | $15.52 | 2023 | V.A.C. Veraflo, V.A.C. Veraflo Cleanse Choice, Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shirene Tabarestani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.